Scandinavian Chemotech Ab Class BOMXSTO: CMOTEC_B

CMOTEC_B: Revenue doubled and losses narrowed, with Animal Care driving growth and US expansion

· Issued by Scandinavian Chemotech Ab Class B

Revenue more than doubled year-over-year, driven by Animal Care, with improved operating cash flow and narrowed losses. Strategic focus on the US and R&D advances position the business for continued growth, despite ongoing financing and market risks.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Scandinavian Chemotech Ab Class B

All Scandinavian Chemotech Ab Class B news releases